# Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)

> **NCT01060878** · PHASE2 · COMPLETED · sponsor: **Phytopharm** · enrollment: 425 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** PYM50028
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01060878
- **Lead sponsor:** Phytopharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 425 (ACTUAL)
- **Last updated:** 2013-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060878, "Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01060878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*